Immunogenicity for Biotherapeutics 2012

This year's program was a tremendous success, and we're getting ready to make next year's show even better! Keep watching this space for upcoming updates about the 13th-annual Immunogenicity for Biotherapeutics conference.

12 Reasons to Attend the 12th Annual
Immunogenicity Event

-10 Poster Sessions to Expand Scientific Discussions
-5 Perspectives Comparing FDA and EMEA Guidelines
-4 Panel Discussions Revealing Industry Tools to Reduce Immunogenicity
-7 Countries Represented for Global Regulatory and Pharmaceutical Perspectives
-4 New Technology Comparison Case Studies
-10 Round Table Subject Matter Expert Opportunities
-3 Hour workshop on Strategies for Immunogenicity Assessment of  Biosimilars
-30 Biopharmaceutical Companies Represented
-3 Hours Dedicated to the Fundamentals of Immunogenicity Studies
-5 Approaches for Accurately Predicting Immunogenicity
-6 White Paper Authors Provide Clear Recommendations
-40 Industry Experts Share Best Practices for Immunogenicity Studies